Logos Global Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001792126

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q2 2025 · 49 positions · Total reported value $856.41M · Top-10 concentration 54.7% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 72.7% · 25 new · 19 cut · 20 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +22.9% · vs SPY +8.1% · Prev Value $1.89B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2025 13F filing, Logos Global Management LP disclosed 49 equity positions with a combined reported value of $856.41M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 54.7% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2025 were XBI ($82.93M), IDYA ($70.31M), AKRO ($64.03M). By sector, the heaviest allocations are Health Care 75.5%, Other 24.5%. Versus the prior quarter, allocation shifted toward Health Care (+2.2pp) and away from Other (-2.2pp).

Versus the prior quarter, Logos Global Management LP opened 25 new positions, trimmed 19 and fully exited 20, a turnover rate of 72.7% of positions. The portfolio's overlap with the prior quarter was 42% of names.

The largest new positions opened in Q2 2025 were XBI ($82.93M), JAZZ ($47.75M), BIIB ($25.12M).

Of the 20 positions fully exited versus the prior quarter, the largest were NUVL ($35.46M), XENE ($21.81M), BNTX ($18.21M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2025)

  • XBI SPDR SERIES TRUST · $82.93M
  • JAZZ JAZZ PHARMACEUTICALS PLC · $47.75M
  • BIIB BIOGEN INC · $25.12M
  • UTHR UNITED THERAPEUTICS CORP DEL · $24.42M
  • NBIX NEUROCRINE BIOSCIENCES INC · $18.85M
  • IMCR IMMUNOCORE HLDGS PLC · $18.04M
  • APLS APELLIS PHARMACEUTICALS INC · $17.31M
  • MDGL MADRIGAL PHARMACEUTICALS INC · $15.13M

Fully Exited (vs previous quarter)

  • NUVL NUVALENT INC · prev qtr: $35.46M
  • XENE XENON PHARMACEUTICALS INC · prev qtr: $21.81M · history
  • BNTX BIONTECH SE · prev qtr: $18.21M · history
  • ETNB 89BIO INC · prev qtr: $18.18M
  • SLNO SOLENO THERAPEUTICS INC · prev qtr: $17.86M
  • GERN GERON CORP · prev qtr: $12.72M
  • CRNX CRINETICS PHARMACEUTICALS IN · prev qtr: $11.74M
  • CMPS COMPASS PATHWAYS ADR A FUNSPONSORED ADR 1 ADR REPS 1 ORD SHS · prev qtr: $5.72M · history

Insider Transactions (Form 4)

Latest Logos Global Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Logos Global Management LP is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q2 2026 it reported 68 US equity positions with a combined value of $2.32B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-117248 (status: Approved), registered 2019-08-26
  • Regulatory AUM (Form ADV): $2.25B as of 2026-04-22
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 5 private funds, of which 1 hedge funds

Portfolio Structure

  • 68 positions · $2.32B reported value (Q2 2026)
  • Top 10 holdings = 48.3% of reported value
  • Largest position: ERAS (ERASCA INC COM) at 9.6%
  • Average position size: $34.16M

Sector Tilt

  • Health Care 99.1%
  • Financials 0.1%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 25 new, 18 added, 19 reduced, 20 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 75.5%
Other 24.5%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 1.00M $82.93M 9.68%
9.68%
New
2 3.35M $70.31M 8.21%
8.21%
Reduce
3 1.20M $64.03M 7.48%
7.48%
Hold
4 1.70M $62.54M 7.30%
7.30%
Add
5 450.00K $47.75M 5.58%
5.58%
New
6 700.00K $37.07M 4.33%
4.33%
Add
7 950.00K $26.98M 3.15%
3.15%
Add
8 2.00M $26.70M 3.12%
3.12%
Hold
9 1.50M $25.14M 2.94%
2.94%
Reduce
10 200.00K $25.12M 2.93%
2.93%
New
11 85.00K $24.42M 2.85%
2.85%
New
12 2.20M $20.42M 2.38%
2.38%
Reduce
13 15.00M $19.05M 2.22%
2.22%
Add
14 150.00K $18.85M 2.20%
2.20%
New
15 1.90M $18.09M 2.11%
2.11%
Add
16 575.00K $18.04M 2.11%
2.11%
New
17 850.00K $17.63M 2.06%
2.06%
Add
18 1.00M $17.31M 2.02%
2.02%
New
19 50.00K $15.13M 1.77%
1.77%
New
20 4.22M $14.21M 1.66%
1.66%
Hold
21 100.00K $13.75M 1.60%
1.60%
New
22 3.21M $13.67M 1.60%
1.60%
Hold
23 600.00K $12.21M 1.43%
1.43%
New
24 500.00K $11.55M 1.35%
1.35%
Reduce
25 1.50M $11.04M 1.29%
1.29%
New
26 700.00K $9.88M 1.15%
1.15%
New
27 1.25M $9.82M 1.15%
1.15%
New
28 225.00K $9.46M 1.10%
1.10%
New
29 200.00K $9.44M 1.10%
1.10%
Reduce
30 190.00K $9.25M 1.08%
1.08%
New
31 553.69K $8.94M 1.04%
1.04%
New
32 250.00K $8.87M 1.04%
1.04%
New
33 130.00K $8.21M 0.96%
0.96%
New
34 611.91K $7.51M 0.88%
0.88%
Reduce
35 2.50M $7.22M 0.84%
0.84%
New
36 350.00K $7.02M 0.82%
0.82%
Add
37 625.00K $6.24M 0.73%
0.73%
New
38 2.41M $5.78M 0.68%
0.68%
Reduce
39 200.00K $5.69M 0.66%
0.66%
New
40 850.00K $4.65M 0.54%
0.54%
Add
41 275.00K $4.40M 0.51%
0.51%
Hold
42 1.00M $4.15M 0.48%
0.48%
New
43 700.00K $3.75M 0.44%
0.44%
Add
44 400.00K $3.72M 0.43%
0.43%
New
45 1.85M $2.63M 0.31%
0.31%
Reduce
46 208.91K $2.38M 0.28%
0.28%
Hold
47 473.56K $2.26M 0.26%
0.26%
Reduce
48 109.20K $1.15M 0.14%
0.14%
Reduce
49 66.67K $17.99K 0.00%
0.00%
Hold

FAQ

What did Logos Global Management LP buy in 2025-Q2?

In its 2025-Q2 13F filing, Logos Global Management LP reported 49 equity positions worth $856.41M in aggregate; its largest disclosed positions were XBI ($82.93M), IDYA ($70.31M), AKRO ($64.03M).

How large is Logos Global Management LP's portfolio?

Logos Global Management LP reported $856.41M of long equity holdings across 49 positions as of 2025-Q2. Top-10 holdings account for 54.7% of reported value.

What is Logos Global Management LP's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/logos-global-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →